---
figid: PMC8268239__ijms-22-06737-g001
figtitle: 'Footprint of Kynurenine Pathway in Neurodegeneration: Janus-Faced Role
  in Parkinson’s Disorder and Therapeutic Implications'
organisms:
- Saccharomyces cerevisiae
- Olea europaea
- Thymus vulgaris
- Garcinia mangostana
- Juglans regia
- Acanthus mollis
- Mus musculus
- Rattus norvegicus
- Drosophila melanogaster
- Caenorhabditis elegans
- Homo sapiens
- Danio rerio
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Danio rerio
- Arabidopsis thaliana
pmcid: PMC8268239
filename: ijms-22-06737-g001.jpg
figlink: /pmc/articles/PMC8268239/figure/ijms-22-06737-f001/
number: F1
caption: 'An overview of multiple steps involved in the kynurenine pathway, forming
  two significant metabolites: quinolinic acid and kynurenic acid. Legend: SCZ—schizophrenia,
  KYNU—kynureninase, IDO—indoleamine 2,3-dioxygenase, AFMID—arylformamidase, KMO—kynurenine
  3-monooxygenase, KAT—kynurenine aminotransferase, PD—Parkinson’s disease, ACMSD—2-amino-
  3-carboxymuconate-6-semialdehyde decarboxylase, CoA—coenzyme A, NAD+—nicotinamide
  adenine dinucleotide, TDO—tryptophan-2,3-dioxygenase.'
papertitle: 'The Footprint of Kynurenine Pathway in Neurodegeneration: Janus-Faced
  Role in Parkinson’s Disorder and Therapeutic Implications.'
reftext: Tapan Behl, et al. Int J Mol Sci. 2021 Jul;22(13):6737.
year: '2021'
doi: 10.3390/ijms22136737
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: Parkinson’s disease | Janus-faced role | kynurenine pathway | neurotoxic
  | quinolinic acid | neuroprotective | kynurenic acid
automl_pathway: 0.9495209
figid_alias: PMC8268239__F1
figtype: Figure
redirect_from: /figures/PMC8268239__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8268239__ijms-22-06737-g001.html
  '@type': Dataset
  description: 'An overview of multiple steps involved in the kynurenine pathway,
    forming two significant metabolites: quinolinic acid and kynurenic acid. Legend:
    SCZ—schizophrenia, KYNU—kynureninase, IDO—indoleamine 2,3-dioxygenase, AFMID—arylformamidase,
    KMO—kynurenine 3-monooxygenase, KAT—kynurenine aminotransferase, PD—Parkinson’s
    disease, ACMSD—2-amino- 3-carboxymuconate-6-semialdehyde decarboxylase, CoA—coenzyme
    A, NAD+—nicotinamide adenine dinucleotide, TDO—tryptophan-2,3-dioxygenase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pd
  - Kyat1
  - Hat1
  - Aadat
  - Kyat3
  - Nek1
  - Katnb1
  - Tstd1
  - Id1
  - Idh1
  - Ido2
  - Id2
  - Tel13q
  - Afmid
  - Kmo
  - Kynu
  - Hps3
  - Acmsd
  - Tdo2
  - KYAT1
  - HAT1
  - AADAT
  - KYAT3
  - KATNB1
  - F11R
  - TSTD1
  - IDO1
  - ID1
  - ID2
  - TLX1NB
  - AFMID
  - KMO
  - KYNU
  - ACMSD
  - id1
  - id2a
  - tdo2b
  - tdo2a
  - afmid
  - kmo
  - kynu
  - napbb
  - acmsd
  - HSFB4
  - KAT1
  - PKT4
  - KAT2
  - PKT3
  - KAT3
---
